SG Americas Securities »

Entrada Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $177k 12k 15.11
2023-09-30 $145k 9.2k 15.81

More positions owned by SG Americas Securities

Amazon (AMZN)
iShares MSCI EAFE Index Fund (EFA)
SPDR Gold Trust (GLD)
Cisco Systems (CSCO)
Invesco Qqq Tr Opt Call Option
Apple (AAPL)
iShares MSCI Emerging Markets Indx (EEM)
Meta Platforms Opt Call Option
Spdr S&p 500 Etf (SPY)
iShares Russell 2000 Index (IWM)
Abbvie (ABBV)
Amazon Opt Call Option
Broadcom (AVGO)
Amgen (AMGN)
Caterpillar (CAT)

View all positions for SG Americas Securities

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
T. Rowe Price Associates
Redmile Group
Vanguard Group
Wellington Management Company
72 Investment Holdings
Charles Schwab Investment Management
TD Asset Management
Bank of New York Mellon
Moore Capital Management
Barclays
Corton Capital
Rhumbline Advisers
Bank of America Corporation

View all funds holding Entrada Therapeutics